Both loss-of-function and ALS mutations in TARDBP have been linked to axonopathy and NMJ pathology in several animal and cellular models (Table 1), further implicating TDP-43 as a key player in this disease. Here, TARDBP is linked to amyotrophic lateral sclerosis.